Evidence map›Paper›PMID 34050916›Full record

ArticleAging clinical and experimental research2021

Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-old.

Zarui A Melikyan, Michael Malek-Ahmadi, Kathleen O'Connor, Alireza Atri, Claudia H Kawas, María M Corrada

Open access · hybridAbstract read
In one paragraph

Article in Aging clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Normative Data Estimation in Neuropsychological Tests: A Systematic Review.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2024
    Pooled it
  2. Trial
  3. The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational study.Diabetic medicine : a journal of the British Diabetic Association · 2026
    Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cognitive Screening and Hearing Assessment in Patients With Chronic Tinnitus.Clinical and experimental otorhinolaryngology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zarui A MelikyanInstitute for Memory Impairments and Neurological Disorders, University of California Irvine, 1511 Hewitt Hall, 843 Health Sciences Road, Irvine, CA, 92697, USA. zmelikya@uci.edu.ORCID http://orcid.org/0000-0002-8495-5546
Michael Malek-AhmadiBanner Sun Health Research Institute, Sun City, AZ, USA.ORCID http://orcid.org/0000-0001-9901-3650
Kathleen O'ConnorBanner Sun Health Research Institute, Sun City, AZ, USA.
Alireza AtriBanner Sun Health Research Institute, Sun City, AZ, USA.
Claudia H KawasInstitute for Memory Impairments and Neurological Disorders, University of California Irvine, 1511 Hewitt Hall, 843 Health Sciences Road, Irvine, CA, 92697, USA.
María M CorradaInstitute for Memory Impairments and Neurological Disorders, University of California Irvine, 1511 Hewitt Hall, 843 Health Sciences Road, Irvine, CA, 92697, USA.ORCID http://orcid.org/0000-0002-8168-8593
University of California, Irvine · USBanner Sun Health Research Institute · USBrigham and Women's Hospital · US

Funding

Diversity Supplement to R01AG021055; Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ StudyR01AG021055 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI CORRADA, MARIA, KAWAS, CLAUDIA H. · 2002 to 2024
$36.9M
Arizona Department of Health Services and Arizona Alzheimer's Consortium CTR040636NIA NIH HHS R01 AG021055NIA NIH HHS R01AG021055
6 · The paper itself

Abstract

backgroundCognitive screening is important for the oldest-old (age 90 +). This age group is the fastest growing and has the highest risk of dementia. However, norms and score equivalence for screening tests are lacking for this group.

aimsTo provide norms and score equivalence for commonly used cognitive screening tests for the oldest-old.

methodsData on 157 participants of the Center for Healthy Aging Longevity Study aged 90 + were analyzed. First, we derived norms for (1) subtests and cognitive domains of the in-person Montreal Cognitive Assessment having a maximum score of 30 (MoCA-30) and (2) the total MoCA-22 score, obtained from the in-person MoCA-30 by summing the subtests that do not require visual input to a maximum score of 22. These norms were derived from 124 participants with a Mini-Mental State Examination (MMSE) ≥ 27. Second, we derived score equivalences for MMSE to MoCA-30 and MoCA-22, and MoCA-30 to MoCA-22 using equipercentile equating method with log-linear smoothing, based on all 157 participants.

resultsMoCA-22 total score norms are: mean = 18.3(standard deviation = 2.2). An MMSE score of 27 is equivalent to a MoCA-30 score of 22 and a MoCA-22 score of 16. DISCUSSION AND

conclusionsSubtest, domain and MoCA-22 norms will aid in evaluation of the oldest-old who cannot complete the MoCA-30 or are tested over the phone. The equivalences of the three cognitive tests (MMSE, MoCA-30, MoCA-22) in the oldest-old will facilitate continuity of cognitive tracking of individuals tested with different tests over time and comparison of the studies that use different cognitive tests.

Indexed as

Cognitive DysfunctionAged, 80 and overHumansMass ScreeningMental Status and Dementia TestsNeuropsychological Tests90 +MMSEMoCA-22MoCA-30Oldest-oldScore conversion

Identifiers

PMID34050916
PMCPMC8668848
OpenAlexW3165060638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.